Plasma Resolvin D2 to Leukotriene B4 Ratio Is Reduced in Diabetic Patients with Ischemic Stroke and Related to Prognosis.

Zhijuan MiaoXin TangMarianne SchultzbergYuwu Zhao Xiuzhe Wang

Published in: BioMed research international (2021)

Our study indicated that the balance between pro-resolving and proinflammatory mediators was impaired by diabetes in ischemic stroke. The RvD2/LTB4 ratio may serve as a biomarker of prognosis for ischemic stroke.

Keyphrases

atrial fibrillation
type diabetes
cardiovascular disease
glycemic control
anti inflammatory
wound healing
skeletal muscle
adipose tissue